NL FR EN
www.belgium.be
2002 - 2003
DR/01 Cure through substitute treatments in Belgium: development of a model for assessment of types of care and patients
DR/02 Action Research on methadone provision through community pharmacists in Belgium
DR/03 Drugs and Nuisance. Study of the phenomenon, the control and the effects of Drug related nuisance, all this from different perspectives
DR/04 Prognosis value from an integrative model of vulnerability based on a French and Dutch adaptation of ASAM criteria in the choice of treatment method for drug addicts
DR/05 Feasibility study on the evaluation of treatment services for patients with dual disorders
DR/06 Psychopathological effects of cannabis use: a critical analysis of the scientific data and methodologies
2003 - 2004
DR/07 Substitute treatments in Belgium, Development of a model for assessment of types of care and patients (Phase II)
DR/08 Effectiveness of inpatient treatment programs for dually diagnosed patients
DR/09 Meta-analysis on the impact of local projects on drug-related nuisance (METAN)
DR/10 Heroin Delivery under Control: feasibility and follow-up study (DHCo)
DR/11 Problematic drug use
DR/12 Problematic drug use
DR/13 To establish a method for evaluating the illicit drug policy in Belgium within the health care sector
DR/14 Meta-analysis concerning the effectiveness and efficiency of the medicinal use of cannabis
DR/15 Action Research on methadone provision through community pharmacists in Belgium
2004 - 2005
DR/16 Effects of the different judicial treatments for drug users
DR/17 Effectiveness and efficiency of the drugs of substitutions (SUBST-OP)
DR/18 Longitudinal study about the impact of cannabis use on the mental and psychosocial health
DR/19 Driving under the influence of psychoactive substances (ROPS)
DR/20 Implementation of the knowledge concerning drugs by the police and the magistracy
DR/21 Effectiveness of inpatient treatment programs for dually diagnosed patients
DR/22 Monitor integral (local) policy concerning drugs
DR/24 Drugs in figures II
2005 - 2006
DR/16 Effects of the different judicial treatments for drug users
DR/18 Longitudinal study about the impact of cannabis use on the mental and psychosocial health
DR/19 Driving under the influence of psychoactive substances (ROPS)
DR/22 Monitor integral (local) policy concerning drugs
DR/24 Drugs in figures II
DR/25 Knowledge and application of evidence-based guidelines in the treatment of substance abuse disorders
DR/26 Drug use and psychopathology in correctional settings
DR/27 Profiling of ecstasy tablets (XTsee)
2006 - 2007
DR/16 Effects of the different judicial treatments for drug users
DR/18 Longitudinal study about the impact of cannabis use on the mental and psychosocial health
DR/28 Treatment trajectories of ethnic minorities in substance abuse treatment
DR/29 nEWS on EWS (N-EWS)
DR/30 Definition and measurement of drug-related crime
DR/31 Chemical profiling of waste from clandestine synthetic drug production
2007 - 2008
DR/29 nEWS on EWS (N-EWS)
DR/30 Definition and measurement of drug-related crime
DR/32 Cocaine and metabolites in waste and surface waters across Belgium
DR/33 Do's en don'ts in a comprehensive and integrated drug policy (DODONBEL)
DR/34 Study of part of locally cultivated cannabis on Belgian market of the drug (GEOCAN)
DR/35 Feasability study about a recurring survey on drug use in the general population (HARPA)
2008 - 2009
DR/34 Study of part of locally cultivated cannabis on Belgian market of the drug (GEOCAN)
DR/36 Essential and supplementary preconditions for the interaction of justice and drug treatment services (JUSTHULP)
DR/37 Trace detection of synthetic drugs production in waste waters (GEOAMP)
DR/38 Drug use among female sex workers in Belgium (DRUSEB)
DR/39 Evaluation of Crisis and Case Management (ECCAM)
2009 - 2010
DR/38 Drug use among female sex workers in Belgium (DRUSEB)
DR/39 Evaluation of Crisis and Case Management (ECCAM)
DR/55 Poly drug use and mental health among drug users who ask for treatment (POLYMEH)
DR/56 Determination of the yield of an illegal indoor cannabis plantation (YILCAN)
DR/57 Drugs in figures (DIC III)
2010 - 2011
DR/38 Drug use among female sex workers in Belgium (DRUSEB)
DR/55 Poly drug use and mental health among drug users who ask for treatment (POLYMEH)
DR/56 Determination of the yield of an illegal indoor cannabis plantation (YILCAN)
DR/57 Drugs in figures (DIC III)
2011 - 2012
DR/58 Analysis and optimization of substitution treatment in Belgium (SUBANOP)
DR/59 Adapting best practice guidelines for the detection, prevention and treatment of substance abuse in children and youngsters to a local Belgian context (ADAPT_YOUTH)
DR/60 Use of alcohol, illegal drugs, hypnotics and tranquilizers in the Belgian population (UP TO DATE)
DR/61 Drug treatment Court Ghent, qualitative outcome evaluation (QUALECT)
DR/62 Indicators for the supply of illegal drugs in Belgium (SUPMAP)
2012 - 2013
DR/59 Adapting best practice guidelines for the detection, prevention and treatment of substance abuse in children and youngsters to a local Belgian context (ADAPT_YOUTH)
DR/60 Use of alcohol, illegal drugs, hypnotics and tranquilizers in the Belgian population (UP TO DATE)
DR/61 Drug treatment Court Ghent, qualitative outcome evaluation (QUALECT)
DR/62 Indicators for the supply of illegal drugs in Belgium (SUPMAP)
DR/63 Cannabis production in Belgium: assessment of the nature and harms, and implications for priority setting (CANMARKT)
DR/64 CompuLsIve Computer use and Knowledge needs in Belgium: A multimethod approach (CLICK)
2013 - 2014
DR/60 Use of alcohol, illegal drugs, hypnotics and tranquilizers in the Belgian population (UP TO DATE)
DR/65 Sociale kost van legale en illegale drugs in Belgïe (SOCOST)
DR/66 Consensus building on minimal quality standards for drug demand reduction in Belgium (COMIQS.BE)
DR/67 Hazards of illicit cannabis cultivation for public, users and intervention staff (HILCAN)
DR/68 Integrated Care for patients with Alcohol Use disorders( ICArUS)
2014 - 2015
DR/65 The social cost of legal and illegal drugs in Belgium (SOCOST)
DR/66 Consensus building on minimal quality standards for drug demand reduction in Belgium (COMIQS.BE)
DR/67 Hazards of illicit cannabis cultivation for public, users and intervention staff (HILCAN)
DR/68 Integrated Care for patients with Alcohol Use disorders( ICArUS)
DR/69 Patterns of drug use among (ethnic and cultural) minorities (PADUMI)
DR/70 PRocess and Outcome Study of Prison-basEd Registration points (PROSPER)
DR/71 The Law of 2009 concerning the selling and serving of alcohol to youths: from state of the art to assessment (ALCOLAW)
2015 - 2016
DR/65 The social cost of legal and illegal drugs in Belgium (SOCOST)
DR/68 Integrated Care for patients with Alcohol Use disorders( ICArUS)
DR/69 Patterns of drug use among (ethnic and cultural) minorities (PADUMI)
DR/70 PRocess and Outcome Study of Prison-basEd Registration points (PROSPER)
DR/71 The Law of 2009 concerning the selling and serving of alcohol to youths: from state of the art to assessment (ALCOLAW)
DR/73 GENder-Sensitive Treatment and prevention services for Alcohol and drug useRs (GEN-STAR)
DR/75 Social prevention of drug related harms (SOCPREV)
2016 - 2017
DR/71 The Law of 2009 concerning the selling and serving of alcohol to youths: from state of the art to assessment (ALCOLAW)
DR/73 GENder-Sensitive Treatment and prevention services for Alcohol and drug useRs (GEN-STAR)
DR/74 The displacement of illicit drug markets from the Netherlands to Belgium: perception or reality? (DISMARK)
DR/75 Social prevention of drug related harms (SOCPREV)
DR/76 Understanding the dynamics and consequences of young adult substance use pathways (ALAMA-nightlife)
DR/77 Assessment of alternative models of regulation alcohol marketing in Belgium (ALMOREGAL)
DR/78 Feasibility study on drug consumption rooms in Belgium (DRUGROOM)
DR/79 Understanding New Psychoactive Substances (NPS) use in Belgium from a health perspective (NPS-care)
DR/80 Recovery pathways and societal responses in the UK, Netherlands and Belgium (REC-PATH)
2017 - 2018
DR/74 The displacement of illicit drug markets from the Netherlands to Belgium: perception or reality? (DISMARK)
DR/75 Social prevention of drug related harms (SOCPREV)
DR/76 Understanding the dynamics and consequences of young adult substance use pathways (ALAMA-nightlife)
DR/77 Assessment of alternative models of regulation alcohol marketing in Belgium (ALMOREGAL)
DR/79 Understanding New Psychoactive Substances (NPS) use in Belgium from a health perspective (NPS-care)
DR/80 Recovery pathways and societal responses in the UK, Netherlands and Belgium (REC-PATH)
DR/81 Perception, habitual use and cessation of benzodiazepines: a multi-method nethnography (BENZO-NET)
2018 - 2019
DR/76 Understanding the dynamics and consequences of young adult substance use pathways (ALAMA-nightlife)
DR/77 Assessment of alternative models of regulation alcohol marketing in Belgium (ALMOREGAL)
DR/79 Understanding New Psychoactive Substances (NPS) use in Belgium from a health perspective (NPS-care)
DR/80 Recovery pathways and societal responses in the UK, Netherlands and Belgium (REC-PATH)
DR/81 Perception, habitual use and cessation of benzodiazepines: a multi-method nethnography (BENZO-NET)
DR/83 The Evaluation of the Belgian Drug Policy (EVADRUG)
DR/84 Mapping the presence of and enhancing substance use treatment for migrants and ethnic minorities (MATREMI)
DR/87 Prevalence and effects of performance enhancing drugs in different groups: lessons for a preventive and curative policy in Belgium (PREVPED)
2019 - 2020
DR/80 Recovery pathways and societal responses in the UK, Netherlands and Belgium (REC-PATH)
DR/81 Perception, habitual use and cessation of benzodiazepines: a multi-method nethnography (BENZO-NET)
DR/82 From the alley to the web. The rise of illicit drug trade on cryptomarkets and the involvement of Belgian buyers and vendors (CRYPTODRUG)
DR/83 The Evaluation of the Belgian Drug Policy (EVADRUG)
DR/84 Mapping the presence of and enhancing substance use treatment for migrants and ethnic minorities (MATREMI)
DR/85 Drugs at the festivals: Perceptions of prevention-, harm reduction-, care-, and law enforcement strategies (POPHARS)
DR/86 Youth perceptions on recreational or non-medical use of psychoactive medications (YOUTH-PUMED)
DR/87 Prevalence and effects of performance enhancing drugs in different groups: lessons for a preventive and curative policy in Belgium (PREVPED)
2020 - 2021
DR/80 Recovery pathways and societal responses in the UK, Netherlands and Belgium (REC-PATH)
DR/81 Perception, habitual use and cessation of benzodiazepines: a multi-method nethnography (BENZO-NET)
DR/83 The Evaluation of the Belgian Drug Policy (EVADRUG)
DR/85 Drugs at the festivals: Perceptions of prevention-, harm reduction-, care-, and law enforcement strategies (POPHARS)
DR/86 Youth perceptions on recreational or non-medical use of psychoactive medications (YOUTH-PUMED)
DR/87 Prevalence and effects of performance enhancing drugs in different groups: lessons for a preventive and curative policy in Belgium (PREVPED)
DR/89 Substance Use and Mental Health care InTegration, a study of service networks in mental health and substance use disorders in Belgium, their accessibility, and the user’s needs (SUMHIT)
DR/90 Outcome Measurement and Evaluation as a Routine practice in alcohol and other drug services in Belgium (OMER-BE)
DR/91 Persons with a BENZOdiazepine/Z-drugs use disorder in mental health CARE (BENZOCARE)
DR/92 Market and Profit Analysis of Illicit Indoor Cannabis Cultivation and Trade (MARCANT)
2021 - 2022
DR/89 Substance Use and Mental Health care InTegration, a study of service networks in mental health and substance use disorders in Belgium, their accessibility, and the user’s needs (SUMHIT)
DR/90 Outcome Measurement and Evaluation as a Routine practice in alcohol and other drug services in Belgium (OMER-BE)
DR/91 Persons with a BENZOdiazepine/Z-drugs use disorder in mental health CARE (BENZOCARE)
DR/92 Market and Profit Analysis of Illicit Indoor Cannabis Cultivation and Trade (MARCANT)
2022 - 2023
DR/89 Substance Use and Mental Health care InTegration, a study of service networks in mental health and substance use disorders in Belgium, their accessibility, and the user’s needs (SUMHIT)
DR/90 Outcome Measurement and Evaluation as a Routine practice in alcohol and other drug services in Belgium (OMER-BE)
DR/91 Persons with a BENZOdiazepine/Z-drugs use disorder in mental health CARE (BENZOCARE)
DR/92 Market and Profit Analysis of Illicit Indoor Cannabis Cultivation and Trade (MARCANT)
DR/93 Rebuilding Evidence on Drug Rooms (Rev-Droom )
DR/94 Improved monitoring of the disease burden attributable to substance use (SUBOD)
DR/95 The relationship between gambling sponsorship and the normalization and prevalence of gambling (GAMSPON )
2023 - 2024
DR/90 Outcome Measurement and Evaluation as a Routine practice in alcohol and other drug services in Belgium (OMER-BE)
DR/91 Persons with a BENZOdiazepine/Z-drugs use disorder in mental health CARE (BENZOCARE)
DR/92 Market and Profit Analysis of Illicit Indoor Cannabis Cultivation and Trade (MARCANT)
DR/93 Rebuilding Evidence on Drug Rooms (Rev-Droom )
DR/94 Improved monitoring of the disease burden attributable to substance use (SUBOD)
DR/95 The relationship between gambling sponsorship and the normalization and prevalence of gambling (GAMSPON )
2024 - 2025
DR/93 Rebuilding Evidence on Drug Rooms (Rev-Droom )
DR/94 Improved monitoring of the disease burden attributable to substance use (SUBOD)
DR/95 The relationship between gambling sponsorship and the normalization and prevalence of gambling (GAMSPON )
2025 - 2026
DR/93 Rebuilding Evidence on Drug Rooms (Rev-Droom )
DR/95 The relationship between gambling sponsorship and the normalization and prevalence of gambling (GAMSPON )